ENDOCRINE TESTING PRODUCT MARKET ANALYSIS

Endocrine Testing Product Market, By Product Type (Instruments/Analyzers and Consumables), By Technology (Liquid Chromatography-Mass Spectrometry, Immunoassay, Tandem Mass Spectroscopy, Sensor Technology, and Others), By Disease Indication (Adrenal Insufficiency and Addison Disease, Bone Disorders, Cancer, Thyroid Disease, and Others), By End User (Hospitals, Clinical Laboratories, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In August 2023, the World Anti-Doping Agency (WADA), an independent international organization dedicated to combating doping in sports, unveiled new features for the Athlete Biological Passport (ABP), including the Endocrine Module. This advancement significantly enhances the detection of human growth hormone (hGH) abuse in sports. The ABP functions as a tool in anti-doping efforts by tracking an athlete's biological markers over time.
In March 2021, F. Hoffmann-La Roche Ltd., a Switzerland-based multinational healthcare company, announced a definitive merger agreement to fully acquire GenMark Diagnostics, a molecular diagnostics firm, for US$ 24.05 per share in an all-cash transaction. This acquisition will enable Roche to enhance its molecular diagnostics portfolio by incorporating GenMark's syndromic panel testing offerings.